ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 131 filers reported holding ARRAY BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $516,000 | -37.3% | 21,200 | -56.8% | 0.03% | +76.5% |
| Q2 2018 | $823,000 | -77.8% | 49,100 | -88.9% | 0.02% | -69.6% |
| Q2 2017 | $3,713,000 | +7800.0% | 443,700 | +2673.1% | 0.06% | +2700.0% |
| Q1 2016 | $47,000 | -81.3% | 16,000 | -71.1% | 0.00% | -89.5% |
| Q3 2015 | $252,000 | -48.5% | 55,400 | -16.6% | 0.02% | -59.6% |
| Q1 2015 | $489,000 | – | 66,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |